paramethasone has been researched along with Diseases, Metabolic in 2 studies
Paramethasone: A glucocorticoid with the general properties of corticosteroids. It has been used by mouth in the treatment of all conditions in which corticosteroid therapy is indicated except adrenal-deficiency states for which its lack of sodium-retaining properties makes it less suitable than HYDROCORTISONE with supplementary FLUDROCORTISONE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p737)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fiegel, G | 1 |
| Kukwa, D | 1 |
| Henrard, JC | 1 |
1 trial available for paramethasone and Diseases, Metabolic
| Article | Year |
|---|---|
[Comparative studies on the effect of different glucocorticoids in the corticoid glucose tolerance test].
Topics: Betamethasone; Blood Glucose; Clinical Trials as Topic; Dexamethasone; Diabetes Mellitus; Fluprednis | 1969 |
1 other study available for paramethasone and Diseases, Metabolic
| Article | Year |
|---|---|
[Current antalgic anti-inflammatory drugs].
Topics: Anti-Inflammatory Agents; Betamethasone; Cortisone; Dexamethasone; Endocrine System Diseases; Eye Di | 1970 |